Here we demonstrate that miR-145 increases sensitivity of pancreatic adenocarcinoma cells to gemcitabine treatment, providing new insights into the role of miR-145/P70S6K1 in mediating gemcitabine chemosensitivity. Here, RPS6KB1 is linked to pancreatic adenocarcinoma.